| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |